DE69735636D1 - Verfahren zur bestimmung des malignen zellezustands und verfahren zur behandlung - Google Patents

Verfahren zur bestimmung des malignen zellezustands und verfahren zur behandlung

Info

Publication number
DE69735636D1
DE69735636D1 DE69735636T DE69735636T DE69735636D1 DE 69735636 D1 DE69735636 D1 DE 69735636D1 DE 69735636 T DE69735636 T DE 69735636T DE 69735636 T DE69735636 T DE 69735636T DE 69735636 D1 DE69735636 D1 DE 69735636D1
Authority
DE
Germany
Prior art keywords
maligning
treating
determining
cell
cell state
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69735636T
Other languages
English (en)
Other versions
DE69735636T2 (de
Inventor
Fabien Calvo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abionyx Pharma SA
Original Assignee
Cerenis SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerenis SA filed Critical Cerenis SA
Publication of DE69735636D1 publication Critical patent/DE69735636D1/de
Application granted granted Critical
Publication of DE69735636T2 publication Critical patent/DE69735636T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Seeds, Soups, And Other Foods (AREA)
DE69735636T 1996-10-31 1997-10-31 Verfahren zur bestimmung des malignen zellezustands und verfahren zur behandlung Expired - Fee Related DE69735636T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9613326 1996-10-31
FR9613326A FR2755148B1 (fr) 1996-10-31 1996-10-31 Procede destine a mettre en evidence l'etat d'une cellule maligne et procede de traitement
PCT/FR1997/001960 WO1998018960A1 (fr) 1996-10-31 1997-10-31 Procede destine a mettre en evidence l'etat d'une cellule maligne et procede de traitement

Publications (2)

Publication Number Publication Date
DE69735636D1 true DE69735636D1 (de) 2006-05-18
DE69735636T2 DE69735636T2 (de) 2007-04-05

Family

ID=9497231

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69735636T Expired - Fee Related DE69735636T2 (de) 1996-10-31 1997-10-31 Verfahren zur bestimmung des malignen zellezustands und verfahren zur behandlung

Country Status (8)

Country Link
US (1) US6277575B1 (de)
EP (1) EP0941364B1 (de)
JP (1) JP2001503261A (de)
AT (1) ATE322553T1 (de)
CA (1) CA2269865A1 (de)
DE (1) DE69735636T2 (de)
FR (1) FR2755148B1 (de)
WO (1) WO1998018960A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ849200A0 (en) * 2000-06-30 2000-07-27 Cea Technologies Inc. Unsupervised scene segmentation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264343A (en) * 1990-08-31 1993-11-23 Eleanor Roosevelt Institute Method for distinguishing normal and cancer cells
US5817462A (en) * 1995-02-21 1998-10-06 Applied Spectral Imaging Method for simultaneous detection of multiple fluorophores for in situ hybridization and multicolor chromosome painting and banding
CA2060267A1 (en) * 1991-02-22 1992-08-23 Joe W. Gray Chromosome specific staining to detect genetic rearrangements
US5506098A (en) * 1991-09-04 1996-04-09 Daikin Industries, Ltd. In situ hybridization method
CA2156920A1 (en) * 1993-02-24 1994-09-01 Stephen N. Thibodeau Tumor-specific genomic instability as a prognostic indicator
WO1995009928A1 (en) * 1993-10-06 1995-04-13 The Regents Of The University Of California Methods for detecting cancer-associated chromosome deletions using in situ hybridization
WO1995013375A1 (en) * 1993-11-10 1995-05-18 The Johns Hopkins University Tumor suppressor waf1
AU5297496A (en) * 1995-02-17 1996-09-04 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Methods of preparation and use of recombinant adenoviral vectors
US5707808A (en) * 1996-04-15 1998-01-13 The Regents Of The University Of California Optical selection and collection of DNA fragments

Also Published As

Publication number Publication date
DE69735636T2 (de) 2007-04-05
EP0941364B1 (de) 2006-04-05
FR2755148B1 (fr) 1999-01-29
EP0941364A1 (de) 1999-09-15
WO1998018960A1 (fr) 1998-05-07
ATE322553T1 (de) 2006-04-15
FR2755148A1 (fr) 1998-04-30
JP2001503261A (ja) 2001-03-13
US6277575B1 (en) 2001-08-21
CA2269865A1 (fr) 1998-05-07

Similar Documents

Publication Publication Date Title
CY1111590T1 (el) Αρυλ και ετεροαρυλ ουριας αναστολεις chk1 για χρηση ως ραδιοευαισθοποιητες και χημειοευαισθητοποιητες
DE69921156D1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
ATE541053T1 (de) Verfahren und zusammensetzungen zur behandlung von nichtkleinzelligem lungenkrebs
SE8704458D0 (sv) Elektrodanordning for inforande i ett levande vesens kropp
DE69919403D1 (de) Verwendung von nikotinsäurederivate zur behandlung von dna-schäden bei hautzellen
ATE404240T1 (de) Vorrichtung zur behandlung von biologischen geweben mittels elektrizität oder medikamenten
ATE353657T1 (de) Verwendung von immunerregenden oligonukleotiden zur vorbeugung oder behandlung von asthma
ATE451362T1 (de) Salze von liponsaürederivaten und deren verwendung bei der behandlung von krankheiten
DE69631738D1 (de) Medizinische implantierbare Vorrichtung für elektrochemische Messungen von Bluteigenschaften
CY1107715T1 (el) Διαγνωση και αγωγη του καρκινου του προστατη
TR199902803T2 (xx) VCAM-1' in te�hisinin daralt�lmas� i�in bile�ikler ve metodlar.
DE69736183D1 (de) Verwendung von topiramat oder derivate davon zur herstellung eines arzneimittels zur behandlung von manisch-depressiven bipolaren störungen
ATE258796T1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
ATE356995T1 (de) Verfahren zur identifizierung von mitteln zur behandlung von diabetes
DE60044350D1 (de) Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs
Harper et al. DNA synthesis among uninvolved and involved psoriatic epidermal cells and normal epidermal cells in vitro
ATE203766T1 (de) Teil der intronsequenz des von hippel-lindau(vhl)-gens und seine verwendung zur krankheitsdiagnose
DE69735636D1 (de) Verfahren zur bestimmung des malignen zellezustands und verfahren zur behandlung
Becker Electromagnetic controls over biological growth processes
DE59508509D1 (de) Dna-expressionsvektoren zur verwendung in der gentherapeutischen behandlung von gefässerkrankungen
DE69838553D1 (de) Verfahren zur diagnose, prognose und behandlung von glaukom und verwandten erkrankungen
Watanabe et al. Chromosomal instability and cellular hypersensitivity to X-radiation of cultured fibroblasts derived from porokeratosis patients' skin
DE59406750D1 (de) Vorrichtung zur behandlung von krankhaften zellen im lebenden körper
ATE206052T1 (de) Verwendung von sphingosin-1-phosphat, sphingosin- 1-phosphat-derivaten und/oder deren gemische zur behandlung von entzündlichen hautkrankheiten
DE60328784D1 (de) Oxaliplatin-antiresistenzverfahren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee